Bayer gets full rights to Vitrakvi, LOXO-195 from Lilly’s Loxo Oncology

Image: Bayer obtains full rights to oncology compounds Vitrakvi, LOXO-195 from Loxo Oncology. Photo: courtesy of Bayer AG.